Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 9, 2010, Pages 1315-1323

  Blin, Nicolas ^a   Traineau, Richard ^a   Houssin, Stéphanie ^b   Peffault de Latour, Régis ^a   Petropoulou, Anna ^a   Robin, Marie ^a   Larghero, Jérôme ^a   Ribaud, Patricia ^a,c   Socié, Gérard ^a,c,d  

^a SAINT LOUIS HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

Author keywords

ABO incompatibility; Acute graft versus host disease; Bone marrow; Hematopoietic recovery; Transfusion needs

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HEMAGGLUTININ; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; FANCONI ANEMIA; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 77955511925     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.03.021     Document Type: Article

References (35)

1. Klumpp T.R. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991, 8:159-170.
2. Petz L.D. Hemolysis associated with transplantation. Transfusion 1998, 38:224-228.
3. Gmur J.P., Burger J., Schaffner A., et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990, 75:290-295.
4. Braine H.G., Sensenbrenner L.L., Wright S.K., et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982, 60:420-425.
5. Bensinger W.I., Buckner C.D., Clift R.A., et al. Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant. J Clin Apheresis 1987, 3:174-177.
6. Hows J., Beddow K., Gordon-Smith E., et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986, 67:177-181.
7. Gajewski J.L., Petz L.D., Calhoun L., et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without post-transplant methotrexate. Blood 1992, 79:3076-3085.
8. Mielcarek M., Leisenring W., Torok-Storb B., et al. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence of graft-versus-plasma cell effect. Blood 2000, 96:1150-1156.
9. Kimura F., Sato K., Kobayashi S., et al. Impact of ABO-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 2008, 93:1686-1693.
10. Bacigalupo A., Van Lint N.T., Occhini D., et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988, 45:1091-1094.
11. Hows J.M., Chipping P.M., Palmer S., et al. Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anemia. Br J Haematol 1983, 53:145-151.
12. Mehta J., Powles R., Sirohi B., et al. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?. Bone Marrow Transplant 2002, 29:853-859.
13. Mielcarek M., Torok-Storb B., Storb R. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 2002, 30:547-548. [letter].
14. Benjamin R.J., McGurk S., Ralston M.S., et al. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999, 39:179-187.
15. Kalaycioglu M., Copelan E., Avalos B., et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995, 15:105-110.
16. Stussi G., Seebach L., Muntwyler J., et al. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-center experience. Br J Haematol 2001, 113:251-253.
17. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001, 344:175-181.
18. Champlin R.E., Schmitz N., Horowitz M.M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000, 95:3996-4003.
19. Buckner C.D., Clift R.A., Sanders J.E., et al. ABO-incompatible marrow transplants. Transplantation 1978, 26:233-238.
20. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
21. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data 1980, Wiley, New York.
22. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc B 1972, 34:187-220.
23. Zand M.S., Vo T., Pellegrin T., et al. Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood 2006, 107:2895-2903.
24. Zand M.S., Vo T., Huggins J., et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005, 79:1507-1515.
25. Benjamin R.J., Connors J.M., McGurk S., et al. Prolongederythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 1998, 4:151-156.
26. Maciej Zaucha M., Mielcarek M., Takatu A., et al. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Br J Haematol 2002, 119:740-750.
27. Kim J.G., Sohn S.K., Kim D.H., et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005, 35:489-495.
28. Kanda Y., Tanosaki R., Nakai K., et al. Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor. Br J Haematol 2002, 118:128-131.
29. Bolan C.D., Leitman S.F., Griffith L.M., et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible non-myeloablative hematopoietic stem cell transplantation. Blood 2001, 98:1687-1694.
30. Veelken H., Wasch R., Behringer D., et al. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant 2000, 26:911-915.
31. Benjamin R.J., McGurk S., Ralston M.S., et al. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999, 39:1273-1274.
32. Maschan A.A., Skorobogatova E.V., Balashov D.N., et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002, 30:405-407.
33. Grzegorz H., Stella-Holowiecka B., Krawczyk-Kulis M., et al. Successful treatment of pure red cell aplasia with repeated, low dose of rituximab in 2 patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Haematologica 2005, 90:e93-e96.
34. Rabitsch W., Knobl P., Prinz E., et al. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption. Bone Marrow Transplant 2003, 32:1015-1019.
35. Deotare U.R., Vishwabandya A., Mathews V., et al. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant 2006, 37:1149-1150.